TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/22/20 17:39 | 7/20/20 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Shenk Thomas E | NY | D | S | -100 | 15.00 | 0 | -7 | -4 | 157 | I | |||||||||||||||
5/13/20 17:37 | 5/11/20 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Shenk Thomas E | NY | D | S | -33 | 15.00 | 0 | -2 | -1 | 164 | I | |||||||||||||||
4/22/20 17:00 | 4/20/20 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Shenk Thomas E | NY | D | S | -67 | 15.00 | 0 | -4 | -3 | 166 | I | |||||||||||||||
4/9/09 16:02 | 4/7/09 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Shenk Thomas E | CA | D | M.d | 454 | 12.97 | 0 | 35 | 8 | D | ||||||||||||||||
3/15/05 13:58 | 3/14/05 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Shenk Thomas E | CA | D | P | 20 | 20.36 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |